BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 20061547)

  • 1. Innate immunity mediates myocardial preconditioning through Toll-like receptor 2 and TIRAP-dependent signaling pathways.
    Dong JW; Vallejo JG; Tzeng HP; Thomas JA; Mann DL
    Am J Physiol Heart Circ Physiol; 2010 Mar; 298(3):H1079-87. PubMed ID: 20061547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TLR2 ligands induce cardioprotection against ischaemia/reperfusion injury through a PI3K/Akt-dependent mechanism.
    Ha T; Hu Y; Liu L; Lu C; McMullen JR; Kelley J; Kao RL; Williams DL; Gao X; Li C
    Cardiovasc Res; 2010 Sep; 87(4):694-703. PubMed ID: 20421349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor 2 modulates left ventricular function following ischemia-reperfusion injury.
    Sakata Y; Dong JW; Vallejo JG; Huang CH; Baker JS; Tracey KJ; Tacheuchi O; Akira S; Mann DL
    Am J Physiol Heart Circ Physiol; 2007 Jan; 292(1):H503-9. PubMed ID: 16980352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphine preconditioning confers cardioprotection in doxorubicin-induced failing rat hearts via ERK/GSK-3β pathway independent of PI3K/Akt.
    He SF; Jin SY; Wu H; Wang B; Wu YX; Zhang SJ; Irwin MG; Wong TM; Zhang Y
    Toxicol Appl Pharmacol; 2015 Nov; 288(3):349-58. PubMed ID: 26296503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin suppresses ischemic preconditioning-mediated cardioprotection through Akt-dependent mechanisms.
    Fullmer TM; Pei S; Zhu Y; Sloan C; Manzanares R; Henrie B; Pires KM; Cox JE; Abel ED; Boudina S
    J Mol Cell Cardiol; 2013 Nov; 64():20-9. PubMed ID: 23994159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium-sensing receptor: a sensor and mediator of ischemic preconditioning in the heart.
    Sun J; Murphy E
    Am J Physiol Heart Circ Physiol; 2010 Nov; 299(5):H1309-17. PubMed ID: 20833954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential role of Toll-interleukin 1 receptor domain-containing adaptor protein in Toll-like receptor 2-mediated regulation of gene expression of hepatic cytokines and drug-metabolizing enzymes.
    Ghose R; Guo T; Vallejo JG; Gandhi A
    Drug Metab Dispos; 2011 May; 39(5):874-81. PubMed ID: 21303924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor 4 and Toll-IL-1 receptor domain-containing adapter protein (TIRAP)/myeloid differentiation protein 88 adapter-like (Mal) contribute to maximal IL-6 expression in macrophages.
    Schilling D; Thomas K; Nixdorff K; Vogel SN; Fenton MJ
    J Immunol; 2002 Nov; 169(10):5874-80. PubMed ID: 12421970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptor 4 signaling confers cardiac protection against ischemic injury via inducible nitric oxide synthase- and soluble guanylate cyclase-dependent mechanisms.
    Wang E; Feng Y; Zhang M; Zou L; Li Y; Buys ES; Huang P; Brouckaert P; Chao W
    Anesthesiology; 2011 Mar; 114(3):603-13. PubMed ID: 21270629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of ischemia postconditioning on ischemia-reperfusion injury and reperfusion injury salvage kinase signal transduction pathways in isolated mouse hearts].
    Zhang JF; Ma YT; Yang YN; Gao XM; Liu F; Chen BD; Li XM; Xiang Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Feb; 36(2):161-6. PubMed ID: 19099957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of B-type natriuretic peptide in epoxyeicosatrienoic acid-mediated improved post-ischaemic recovery of heart contractile function.
    Chaudhary KR; Batchu SN; Das D; Suresh MR; Falck JR; Graves JP; Zeldin DC; Seubert JM
    Cardiovasc Res; 2009 Jul; 83(2):362-70. PubMed ID: 19401302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GSK-3β at the crossroads in the signalling of heart preconditioning: implication of mTOR and Wnt pathways.
    Vigneron F; Dos Santos P; Lemoine S; Bonnet M; Tariosse L; Couffinhal T; Duplaà C; Jaspard-Vinassa B
    Cardiovasc Res; 2011 Apr; 90(1):49-56. PubMed ID: 21233250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remifentanil Preconditioning Reduces Postischemic Myocardial Infarction and Improves Left Ventricular Performance via Activation of the Janus Activated Kinase-2/Signal Transducers and Activators of Transcription-3 Signal Pathway and Subsequent Inhibition of Glycogen Synthase Kinase-3β in Rats.
    Qiao S; Mao X; Wang Y; Lei S; Liu Y; Wang T; Wong GT; Cheung CW; Xia Z; Irwin MG
    Crit Care Med; 2016 Mar; 44(3):e131-45. PubMed ID: 26468894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldose reductase modulates cardiac glycogen synthase kinase-3β phosphorylation during ischemia-reperfusion.
    Abdillahi M; Ananthakrishnan R; Vedantham S; Shang L; Zhu Z; Rosario R; Zirpoli H; Bohren KM; Gabbay KH; Ramasamy R
    Am J Physiol Heart Circ Physiol; 2012 Aug; 303(3):H297-308. PubMed ID: 22661511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival kinase-dependent pathways contribute to gender difference in the response to myocardial ischemia-reperfusion and ischemic post-conditioning.
    Ciocci Pardo A; Scuri S; González Arbeláez LF; Caldiz C; Fantinelli J; Mosca SM
    Cardiovasc Pathol; 2018; 33():19-26. PubMed ID: 29414428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of the cardioprotective effect of ischemic preconditioning in hyperlipidaemic rat heart.
    Yadav HN; Singh M; Sharma PL
    Eur J Pharmacol; 2010 Sep; 643(1):78-83. PubMed ID: 20598682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage migration inhibitory factor plays an essential role in ischemic preconditioning-mediated cardioprotection.
    Ruze A; Chen BD; Liu F; Chen XC; Gai MT; Li XM; Ma YT; Du XJ; Yang YN; Gao XM
    Clin Sci (Lond); 2019 Mar; 133(5):665-680. PubMed ID: 30804219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II-preconditioning is associated with increased PKCε/PKCδ ratio and prosurvival kinases in mitochondria.
    Nuñez RE; Javadov S; Escobales N
    Clin Exp Pharmacol Physiol; 2017 Dec; 44(12):1201-1212. PubMed ID: 28707739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protease-activated receptor 2-mediated protection of myocardial ischemia-reperfusion injury: role of transient receptor potential vanilloid receptors.
    Zhong B; Wang DH
    Am J Physiol Regul Integr Comp Physiol; 2009 Dec; 297(6):R1681-90. PubMed ID: 19812353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of the innate immune NLRP3 receptor abolishes cardiac ischemic preconditioning and is associated with decreased Il-6/STAT3 signaling.
    Zuurbier CJ; Jong WM; Eerbeek O; Koeman A; Pulskens WP; Butter LM; Leemans JC; Hollmann MW
    PLoS One; 2012; 7(7):e40643. PubMed ID: 22848390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.